Clinical trial
Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention Through Identification and Deep Phenotyping Methods in Healthy Aging and High-burden Disease Cohorts.
NCT06073106 is registered in ClinicalTrials.gov with Tan Tock Seng Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention Through Identification and Deep Phenotyping Methods in Healthy Aging and High-burden Disease Cohorts.
- Lead sponsor
- Tan Tock Seng Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 1, 2025
- Completion date
- January 31, 2027
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, knee osteoarthritis, stroke, traumatic brain injury